Discontinued — last reported Q3 '24
International Flavors & Fragrances Health & Biosciences — Goodwill, Impaired, Accumulated Impairment Loss remained flat by 0.0% to $2.25B in Q3 2024 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.25B to $2.25B. This is a positive signal — lower values indicate better performance for this metric.
An increase signals that previous acquisitions are underperforming or that market conditions have negatively impacted the segment's long-term value.
This metric tracks the cumulative losses recognized when the carrying amount of goodwill in the Health & Biosciences seg...
Standard impairment testing metric required under GAAP/IFRS for all companies with significant acquisition history.
iff_segment_health_biosciences_goodwill_impaired_accumulated_impairment_loss| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|
| Value | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | +0.0% | — | — | +0.0% |